Hjem › Ewing-sarkom › Californien › Los Angeles
Ewing-sarkom kliniske forsøg i Los Angeles, CA
6 studier for Ewing-sarkom søger deltagere på steder i og omkring Los Angeles (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
RekruttererFase 1
- Cedars Sinai Medical Center, Los Angeles
- University of California Los Angeles, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RekruttererFase 1
- Valkyrie Clinical Trials, Los Angeles
Lurbinectedin in FET-Fused Tumors
RekruttererFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
RekruttererFase 1/2
- Children's Hospital of Los Angeles, Los Angeles
Ewing-sarkom forsøg i andre byer
- New York City, NY8 studier
- Houston, TX7 studier
- Philadelphia, PA7 studier
- Memphis, TN7 studier
- Washington, DC6 studier
- Boston, MA6 studier
- Aurora, CO6 studier
- Atlanta, GA5 studier
- Birmingham, AL5 studier
- Columbus, OH4 studier
- Tampa, FL4 studier
- Baltimore, MD4 studier
Andre studier i Los Angeles
- Ikke-småcellet lungecancer87 studier
- Kræft (alle typer)73 studier
- Brystkræft72 studier
- Prostatakræft61 studier
- Colorektal kræft59 studier
- Metastatisk cancer57 studier
- Ægstockræft50 studier
- Lungecancer45 studier
- Pladecellekræft i hoved og hals42 studier
- Bugspytkirtelkræft35 studier
- Livmoderslimhindekræft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.